News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024
Jul 24, 2024, 01:00

Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024

Yige Bao, Oncological Urologist and Microbiome researcher in West China Hospital, shared a post on X:

“Exciting news! Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024 (European Society for Medical Oncology Congress 2024)! Demonstrating the potential to preserve kidneys in carefully selected high-risk UTUC patients.”

Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024

Source: Yige Bao/X

cancer ESMO 2024 European Society for Medical Oncology kidney cancer OncoDaily Oncology UTUC nephron-sparing trial UTUC patients West China Hospital Yige Bao
Special Coverage
Voices
Aug 25, 2025, 19:00
Jarushka Naidoo: Irish Oncology in Full Force at the ESMO Academy 2025
Voices
Aug 25, 2025, 18:30
Shadha S. Al-Raisi: The Latest Cancer Incidence Report in Oman Has Been Released
Insight
Aug 25, 2025, 17:47
Alexey Kulikov: Key Findings from the Recent Meta-Analysis on Daily Steps and Health Outcomes
Voices
Aug 25, 2025, 17:36
Lauren Kriger Groner: Learning to Make White Ribbons from the Very Best
Science
Aug 25, 2025, 17:28
Galip Can Uyar: How GA-Guided Care Improves Coping in Older Adults with Metastatic Cancer
Science
Aug 25, 2025, 17:18
Giuseppe Banna: Deferred Nephrectomy after ICI in RCC May Enable Treatment De-Escalation
Science
Aug 25, 2025, 17:08
Moazzam Shahzad: Upfront Immunotherapy Approaches in the Management of Adults with ALL
Science
Aug 25, 2025, 17:00
Chris Poulios: Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
Voices
Aug 25, 2025, 16:44
Martin Zapata Laguado: Honored to Speak on mRCC First-Line Therapy and dCN in the IO Era
Voices
Aug 25, 2025, 16:30
Sarcoma 101 at Fellowship Bootcamp with Steve Bialick - Miami Hematology Oncology Program Director
Science
Aug 25, 2025, 16:04
George Kumar Shares Breakthrough in Cold Plasma Oncology
Voices
Aug 25, 2025, 15:59
Cancer Research Institute Highlights Its Role in Immune-Based Cancer Breakthroughs